ランキングに戻る

Addus HomeCare Corporation (ADUS)

POSITIVE
HealthcareMedical Care FacilitiesUnited States

ファンダメンタル

75

株価

$120.83

時価総額

$2.27B

パート1 · 企業の価値

概要

Addus HomeCare Corporation has provided home-based care in the United States since 1979. It sends caregivers and clinicians into people's homes rather than treating them in a facility, operating three segments: personal care (non-medical help with daily living), hospice (end-of-life care) and home health (short-term skilled nursing and therapy). As of December 31, 2025 it operated roughly 262 offices across 23 states, served about 107,000 discrete consumers during the year and employed 50,659 people, of whom 49,948 were caregivers and agency staff. Its consumers are predominantly 'dual eligible' — entitled to both Medicare and Medicaid — and the business is built on the premise that care at home costs less than care in an institution and is what families prefer. It provides all three levels of care in Ohio, Tennessee, Illinois and New Mexico, and grows both organically and by buying small local agencies (four acquisitions in 2025).

収益の仕組み

Addus is paid by government programmes and their intermediaries, not by patients. In 2025 it derived about 39.3% of net service revenues from state and local governmental agencies (mostly Medicaid programmes) and about 20.5% from Medicare, with the balance from managed care organisations, commercial insurers, the Veterans Health Administration and private pay. Personal care is billed on an hourly or unit-of-service basis at rates each state sets; hospice is paid a daily rate per enrolled patient under the Medicare Hospice Prospective Payment System; home health is paid a standardised 30-day period rate adjusted for case mix under Medicare's Patient-Driven Groupings Model. Contracts with state and local agencies typically run one to two years initially, can be cancelled on 60 days' notice, and are usually renewed for one to five years. Revenue therefore moves with three things the company does not control: authorised hours, reimbursement rates set by legislatures and CMS, and the wage it must pay caregivers.

セグメント別売上高

Personal care76.6%

Non-medical help with the activities of daily living — bathing, grooming, feeding, dressing, medication reminders, meal preparation, housekeeping and transport — for elderly, chronically ill or disabled people at risk of hospitalisation or institutionalisation, plus staffing services sold to assisted living facilities, nursing homes and hospices. Revenue was $1,089.2 million in 2025.

Hospice18.5%

Physical, emotional and spiritual care for terminally ill patients — generally with a life expectancy of six months or less — and support for their families, including palliative nursing, social work, spiritual counselling, homemaker services and bereavement counselling. Revenue was $262.5 million in 2025.

Home health5%

Medical services at home — skilled nursing and physical, occupational and speech therapy — provided on a short-term, intermittent or episodic basis to people recovering from an illness, injury or hospital stay. Revenue was $70.8 million in 2025.

競争優位性(moat)

規模の経済 · 狭い

The company itself describes its industry as highly competitive, fragmented and market-specific, with no single competitor holding significant share across all its markets — that is the opposite of a fortress. What advantage exists is local and regulatory rather than universal: Addus is one of the larger providers in the states where it concentrates, which makes it a more useful partner for managed care organisations that are narrowing their provider networks, and it can offer all three levels of care in Ohio, Tennessee, Illinois and New Mexico. The 10-K also argues that licensing requirements, electronic visit verification mandates, rising operating and technology complexity and pressure on reimbursement rates 'may discourage new providers and may encourage industry consolidation'. Those are real but narrow barriers: they raise the cost of entry without giving Addus pricing power, since rates are set by states and CMS, and its consumers can pick any authorised provider from a list.

需要を左右する要因

ディフェンシブ

What Addus sells is not discretionary: help with bathing, dressing and eating for frail elderly and disabled people, and care for the dying. Demand comes from the ageing of the US population and from the preference — shared by families and by payors trying to cut cost — for care at home rather than in an institution, and the company expects demand for home and community-based services to keep growing for those reasons. The cycle that matters here is fiscal rather than economic: revenue depends on state budgets and on rates set by legislatures and CMS. Illinois, for instance, raised its in-home hourly rate to $29.63 from January 2025 and to $30.80 from January 2026, each time alongside a higher mandated minimum wage for direct service workers ($18.00, then $18.75 per hour) — so a good year is one where the rate increase covers the wage increase. Volumes are also constrained by supply: growth depends on state agencies authorising new consumers and on Addus being able to hire enough caregivers to serve them.

主なリスク

  • Revenue is concentrated in a handful of states — In 2025 Addus derived approximately 37.0% of net service revenues from Illinois, 15.2% from Texas and 13.1% from New Mexico. Because so much of the business sits in a small number of states, any change in the demographic, economic, competitive or regulatory conditions there — including changes to those states' Medicaid programmes — could have a disproportionately negative effect.
  • Cuts to Medicare and Medicaid reimbursement — About 39.3% of 2025 revenue came from state and local government agencies, mainly Medicaid, and about 20.5% from Medicare. The Budget Control Act imposes a 2% across-the-board Medicare reduction running through most of 2032, and the company flags that the OBBBA is expected to produce Medicaid spending reductions and restrict state financing mechanisms such as provider taxes and state directed payments. Home and community-based services are optional under Medicaid, so they are exposed when states have to cut.
  • Dependence on one payor: the Illinois Department on Aging — The Illinois Department on Aging accounted for 18.1% of net service revenues in 2025 (21.0% in 2024). State officials have tried in the past, and may try again, to cut spending at that department; changes to eligibility, to the number of hours authorised, or other restrictions on services would hit revenue and growth directly.
  • Finding and keeping caregivers, at a cost the payor may not cover — Addus competes for caregivers and skilled clinical staff with other providers and with service industries generally. It states that a tight labour market, the increased competition for skilled healthcare staff, possible minimum staffing mandates and changes in immigration policy and enforcement all make hiring harder and have already raised labour costs — and that it may not be able to offset higher labour costs by raising its rates, since those rates are largely set by government payors.
  • Hospice is capped by Medicare — Each hospice provider number is subject to an inpatient cap — no more than 20% of total patient care days may be inpatient — and an aggregate annual cap on total Medicare reimbursement based on the number of Medicare patients served. Payments above either cap must be repaid to Medicare, which the company says could materially affect its financial condition, results and cash flows.
  • Growth by acquisition, and the integration it requires — The company's strategy depends on managing growth and integrating what it buys; it warns that completed or future acquisitions may be unsuccessful and expose it to unforeseen liabilities, that it may be unable to pursue acquisitions or enter new regions without additional capital or lender consent, and that federal and state regulation may impair its ability to close deals or open new agencies. It also warns that a write-down of goodwill or intangible assets would materially hurt net earnings and net worth.
  • Audits, investigations and the regulatory burden — Addus has been and may again be the subject of surveys, audits and investigations by government agencies and private payors, whose adverse findings could hurt the business. More broadly it warns that failure to comply with the extensive laws governing home care — including anti-kickback, false claims, privacy and employment rules on minimum wage, living wage and paid time off — could bring penalties or force changes to its operations.
  • Timing of reimbursement can strain liquidity — The company lists timing differences in reimbursement among its principal risks: it pays caregivers before payors pay it. Receivables from the Illinois Department on Aging alone rose from $26.7 million at the end of 2024 to $38.3 million at the end of 2025, and represented 25.2% of net accounts receivable at December 31, 2025.

顧客集中度

主要顧客が売上高の18.1%を占める

Addus's customers are payors, not patients, and the largest single one is the Illinois Department on Aging, which accounted for 18.1% of net service revenues in 2025, down from 21.0% in 2024 as the Gentiva personal care acquisition diluted it. Beyond that one client, the concentration is geographic and programmatic: Illinois as a whole was 37.0% of 2025 revenue (42.1% of the personal care segment), and within personal care, state, local and other governmental programmes were 50.8% and managed care organisations 46.0% of segment revenue, with commercial insurance, private pay and other payors making up the rest. Receivables from the Illinois Department on Aging were 25.2% of net accounts receivable at December 31, 2025. The filing does not disclose a combined 'top five customers' share.

強気材料

Buyers argue that the demographics do the work: an ageing US population needs help with daily living, and both families and payors prefer the home to the nursing home, which is cheaper. They point to the record — net service revenues of $1,422.5 million in 2025 against $1,154.6 million in 2024, and net income of $95.9 million against $73.6 million — and to a fragmented industry of many small agencies in which a company with 262 offices, 23 states and 50,659 employees can keep buying share, as it did with four acquisitions in 2025 and the Gentiva personal care business in December 2024. They argue that offering all three levels of care in the same market makes Addus more useful to managed care organisations that are narrowing their networks, and that the same rising burden of licensure, electronic visit verification and technology that raises Addus's costs also pushes small operators to sell. They note that Illinois has raised its in-home rate two years running, to $29.63 in 2025 and $30.80 in 2026, and that reliance on the single largest payor has fallen from 21.0% to 18.1% of revenue as the business diversifies.

弱気材料

Sellers fear that a company drawing roughly 39.3% of revenue from state and local agencies and 20.5% from Medicare has handed control of its price to legislatures. The 10-K itself says the OBBBA is expected to reduce Medicaid spending and restrict the financing mechanisms states use, and that home and community-based services are optional under Medicaid — first in line when a state cuts. They fear the geography: 37.0% of 2025 revenue from Illinois, 15.2% from Texas, 13.1% from New Mexico, and 18.1% from one client, the Illinois Department on Aging, whose budget state officials have tried to cut before. They fear the labour squeeze from the other side — the company competes for caregivers in a tight market, faces mandated minimum wages for direct service workers, and says plainly it may not be able to offset higher labour costs by raising rates. They point to the cash mechanics: Addus pays caregivers before payors pay it, and its Illinois Department on Aging receivable grew from $26.7 million to $38.3 million during 2025, reaching 25.2% of net receivables. And they note that growth has leaned on acquisitions, which carry integration risk, unforeseen liabilities and goodwill that could be written down.

Generated on 2026年8月23日 with claude-opus-5 — shared with all users

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 2026年8月23日 with claude-opus-5 — shared with all users

P/E: 36.1Score: 69Market cap: $11.62B

Its Provider Services division delivers home- and community-based personal care, home health and rehabilitation to Medicaid and Medicare populations, overlapping directly with all three of Addus's segments.

Help at Home, LLCNot tracked

Privately held and the closest pure-play rival to Addus's core business, providing non-medical in-home personal care to Medicaid-eligible seniors and disabled adults, competing for the same state Medicaid and managed-care contracts and the same scarce pool of caregivers.

Aveanna Healthcare Holdings, Inc.AVAH

A diversified home care platform that provides in-home nursing, home health and hospice largely funded by Medicaid and managed-care payors, competing for the same patients, referral sources and payor contracts in overlapping states.

The Pennant Group, Inc.PNTG

Operates home health and hospice agencies across fifteen mostly western and southern states, competing with Addus's clinical segments for hospital and physician referrals and for Medicare and managed-care contracts.

貸借対照表と流動性

売上高

$1.48B

直近12か月(2026/6/30まで)

純利益

$105M

直近12か月(2026/6/30まで)

フリーキャッシュフロー

$104M

自己資本合計

$1.09B

負債合計

$352M

流動比率

1.69

利払い倍率

14.91

負債/EBITDA

0.70

一株当たり利益(EPS)

売上高と純利益

フリーキャッシュフロー

収益内訳

財務推移表

利益率の推移

負債の推移

負債の重さ

成長率グリッド

成長率 — 売上高

適正価値の推定

適正価値

適正価値

$155.41

現在株価

$120.83

安全マージン

+22.3%

適正価値レンジ

$101.02 - $209.81

推定方法

Analyst Target:$134.69
DCF:$245.23
PE-based:$91.44
Graham Growth:$246.39
EPV:$69.78
アナリスト・コンセンサス:強い買い (17B / 2H / 1S)
直近の決算サプライズ:-0.18%

バリュエーション指標

P/E レシオ

21.16

ROE

8.8%

P/B レシオ

1.97

P/FCF

14.58

粗利益率

32.4%

ROIC

9.1%

収益性レーダー

Value Creation (Economic Moat)

ROIC

9.1%

WACC

9.1%

ROIC − WACC

-0.0 pp

ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.

ファンダメンタル分析基準

合格(21)

  • EPS shows upward trend
  • Price CAGR 13.17%
  • ROIC 9.1%
  • Gross Margin 32.4%
  • P/FCF 14.58
  • P/B Ratio 1.97
  • Debt/Equity ratio
  • Operating Margin 10.0%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 9.6%
  • Revenue Growth 5Y 13.2%
  • Analyst Consensus 85% Buy
  • PEG Ratio 1.04
  • Earnings Quality (OCF/NI) 1.54
  • Net Margin Trend 7.1% vs 6.5%
  • Piotroski F-Score 7/9

不合格(5)

  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.6%
  • Share Dilution 5.6%

データなし(1)

  • Dividend Payout NaN%

Piotroski F-スコア

7/9

財務健全性が高い

score
criteria

利益の質

1.54

高品質:利益はキャッシュに裏付けられている

株式希薄化

5.6%

新株を発行しており、所有権を希薄化している

ガバナンス

経営陣

氏名役職年齢
Mr. R. Dirk Allison CPACEO & Chairman of the Board69
Mr. Sean P. Gaffney J.D.Executive VP & Chief Legal Officer45
Mr. Darby AndersonExecutive VP & Chief Government Relations Officer59
Mr. Zach SimpsonSenior VP & Chief Accounting Officer-
Mr. Michael D. WattenbargerExecutive VP & Chief Information Officer54
Ms. Monica Raines J.D.Executive VP and Chief Compliance & Quality Officer45
Mr. Roberton James StevensonExecutive VP & Chief Human Resource Officer44
Ms. Diane KumarichSenior Vice President of Payor Innovation-
Mr. Tim StewartSenior VP of IT Infrastructure & Chief Information Security Officer-
Mr. Brian MonahanSenior Vice President of Tax-

監査リスク

4

取締役会リスク

6

報酬リスク

5

株主権利リスク

7

パート2 · 株価と買い時

この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。

Latest News

Recent headlines for ADUS, sourced from Markets Gazette.

No recent news for ADUS.